Literature DB >> 16878273

The use of receptor-specific antibodies to study G-protein-coupled receptors.

Achla Gupta1, Lakshmi A Devi.   

Abstract

The identification of G-protein-coupled receptor (GPCR) cDNAs has facilitated a number of studies characterizing the biochemical properties of the receptor protein. Most of these studies have used antibodies directed against the epitope-tagged receptor expressed in heterologous cells, because of the lack of sensitive and selective antibodies capable of recognizing endogenous receptors in their native state. In order to facilitate studies with endogenous receptors, efforts have been made to generate receptor-type selective, sensitive antibodies that are able to recognize endogenous receptors. In this review, we discuss the strategies as well as the details of the techniques used for the generation of monoclonal and polyclonal antibodies with a focus on family A GPCRs.

Mesh:

Substances:

Year:  2006        PMID: 16878273

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  11 in total

1.  Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies.

Authors:  Achla Gupta; Raphael Rozenfeld; Ivone Gomes; Kirsten M Raehal; Fabien M Décaillot; Laura M Bohn; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2008-02-06       Impact factor: 5.157

2.  Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Authors:  Serena Bodei; Nicola Arrighi; PierFranco Spano; Sandra Sigala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-19       Impact factor: 3.000

Review 3.  Antibodies against G-protein coupled receptors: novel uses in screening and drug development.

Authors:  Achla Gupta; Andrea S Heimann; Ivone Gomes; Lakshmi A Devi
Journal:  Comb Chem High Throughput Screen       Date:  2008-07       Impact factor: 1.339

4.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

5.  Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.

Authors:  Abhishek Tripathi; Vadim Gaponenko; Matthias Majetschak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-14       Impact factor: 3.000

6.  Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies.

Authors:  Franck Talmont; Lionel Moulédous; Jérôme Boué; Catherine Mollereau; Gilles Dietrich
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons.

Authors:  Raphael Rozenfeld; Ittai Bushlin; Ivone Gomes; Nikos Tzavaras; Achla Gupta; Susana Neves; Lorenzo Battini; G Luca Gusella; Alexander Lachmann; Avi Ma'ayan; Robert D Blitzer; Lakshmi A Devi
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

8.  Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states.

Authors:  Andrea S Heimann; Achla Gupta; Ivone Gomes; Rahman Rayees; Avner Schlessinger; Emer S Ferro; Ellen M Unterwald; Lakshmi A Devi
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

9.  In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene.

Authors:  Cyril J Peter; Atsushi Saito; Yuto Hasegawa; Yuya Tanaka; Mohika Nagpal; Gabriel Perez; Emily Alway; Sergio Espeso-Gil; Tariq Fayyad; Chana Ratner; Aslihan Dincer; Achla Gupta; Lakshmi Devi; John G Pappas; François M Lalonde; John A Butman; Joan C Han; Schahram Akbarian; Atsushi Kamiya
Journal:  Nat Commun       Date:  2019-09-11       Impact factor: 17.694

10.  Regulation of Opioid Receptors by Their Endogenous Opioid Peptides.

Authors:  Achla Gupta; Srinivas Gullapalli; Hui Pan; Dinah L Ramos-Ortolaza; Michael D Hayward; Malcom J Low; John E Pintar; Lakshmi A Devi; Ivone Gomes
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.